Helper plasmids for production of HIV-1-derived vectors

Area of Science:

• Gene Therapy
• Viral Vector Development
• Molecular Biology

Background:

• Human immunodeficiency virus type 1 (HIV-1) vectors offer stable gene transfer into noncycling cells, enabling in vivo transduction of various tissues.
• Safety concerns regarding the pathogenic nature of HIV-1 necessitate modifications to vector systems.

Purpose of the Study:

• To engineer safer HIV-1-derived vectors by optimizing the expression of essential viral genes for vector production.
• To reduce the transfer of biologically active viral sequences to transduced cells.

Main Methods:

• Expressed individual transcriptional units for trans functions in separate plasmid constructs.
• Codon-optimized the gag-pol gene sequence for enhanced mammalian cell expression, independent of Rev/Rev-response element (RRE).
• Destroyed the vif reading frame overlapping the 3' end of the pol coding sequence during codon optimization.

Main Results:

• Achieved high-level, Rev/RRE-independent expression of gag-pol.
• Reduced sequence homology between gag-pol and vector sequences, minimizing transfer of active gag-pol.
• Demonstrated efficient expression of Gag and Gag-Pol polyproteins from separate units, removing the gag-pol translational frameshift sequence.

Conclusions:

• Codon optimization of gag-pol enhances vector safety by preventing the transfer of functional gag-pol sequences.
• Separating Gag and Gag-Pol expression units further improves vector safety and production efficiency.
• Developed a safer, modified HIV-1 vector system suitable for gene therapy applications.